Trypsin (2.5 %) in DPBS (10x) Reference: TRY-2B10 Trypsin solution is obtained from porcine pancreas and suitable for cell detachment and dissociation of various cell types. A variety of available formulations suit many applications.
Exo-spin 96 Reference: EX07-96 Exo-spin™ 96 provides proven size exclusion chromatography (SEC) mini-column (EX01) technology in a 96-well format, allowing up to 96 individual samples to be processed in less than 30 minutes. Sample volumes up to 0.5 ml can be purified.
Trypsin-EDTA (0.25 %) in HBSS (1x), with phenol red Reference: TRY-3B Trypsin solution is obtained from porcine pancreas and suitable for cell detachment and dissociation of various cell types. A variety of available formulations suit many applications.
TRIFic CD9 Exosome Assay Reference: EX101 The TRIFic™ exosome detection assay delivers clear and consistent data quickly by providing quantitative data from purified or unpurified samples, including direct measurement of exosomes in plasma in a convenient 96-well format. It is similar to an ELISA assay, but the target is detected directly with a Europium label without any enzymatic reaction. TRIFic™ exosome detection assays are being made available for widely used exosome markers, allowing for identification of CD9+/CD81+/CD63+ - EVs.
Trypsin-EDTA (0.05 %) in HBSS (1x), with phenol red Reference: TRY-4B Trypsin solution is obtained from porcine pancreas and suitable for cell detachment and dissociation of various cell types. A variety of available formulations suit many applications.
TRIFic CD63 Exosome Assay Reference: EX102 The TRIFic™ exosome detection assay delivers clear and consistent data quickly by providing quantitative data from purified or unpurified samples, including direct measurement of exosomes in plasma in a convenient 96-well format. It is similar to an ELISA assay, but the target is detected directly with a Europium label without any enzymatic reaction. TRIFic™ exosome detection assays are being made available for widely used exosome markers, allowing for identification of CD9+/CD81+/CD63+ - EVs.